Tuberculosis (TB) is a chronic infectious disease caused by the bacterium Mycobacterium tuberculosis. Pulmonary TB is the most common form, primarily affecting the lungs. TB is transmitted through the inhalation of respiratory droplets containing M. tuberculosis. The disease can manifest as active TB, latent TB infection, or extrapulmonary TB. Symptoms of active pulmonary TB include persistent cough, chest pain, weight loss, and hemoptysis. Diagnosis involves clinical evaluation, imaging studies, and laboratory tests, such as sputum culture and molecular assays. Treatment typically involves a combination of antibiotics, such as isoniazid, rifampin, and ethambutol, over an extended duration. Preventive measures for pulmonary infections like TB include vaccination with the Bacillus Calmette-Guérin (BCG) vaccine, particularly in regions with high TB prevalence. Public health efforts also focus on early detection, contact tracing, and directly observed therapy to control the spread of TB. Ongoing research explores new diagnostic tools, treatment regimens, and strategies for TB control, especially in the context of emerging drug-resistant strains.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation